IGF1R and hepatocellular carcinoma: In contrast, our preliminary study demonstrated the superiority of integrative therapy regarding HBeAg clearance, and in this study, we found that TGYP could downregulate the expression of IGF1R, thereby playing a role in the inhibition of HBV-related HCC.